Companies: 10,795·Total market cap: $144.5T
Rentokil Initial plc

Rentokil Initial plc

RTONYSEIndustrials● Active
$29.84
+$0.14(+0.47%)
Market Cap$15.0B
P/E Ratio
52W High$34.67
52W Low$22.72
Overview

Rentokil Initial plc (RTO) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · RTO · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$6.91B$5.44B$5.38B$3.71B$2.95B
Cost of Revenue$5.97B$4.71B$0.93B$0.70B$0.60B
Gross Profit$0.95B$0.73B$4.45B$3.01B$0.73B
Gross Margin %(computed)13.68%13.36%82.75%81.04%24.67%
Operating Expenses
R&D Expenses$0.00B$0.01B$0.00B$0.01B$0.01B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.00B$0.18B$3.82B$2.69B$2.01B
Operating Income$0.95B$0.55B$0.63B$0.32B$0.35B
Operating Margin %(computed)13.68%10.10%11.63%8.54%11.75%
Interest Income$0.03B$0.04B$0.03B$0.01B$0.00B
Interest Expense$0.06B$0.19B$0.19B$0.08B$0.03B
Income Before Tax$0.39B$0.41B$0.49B$0.30B$0.33B
Income Tax Expense$0.10B$0.10B$0.11B$0.06B$0.06B
Net Income$0.47B$0.31B$0.38B$0.23B$0.26B
Net Margin %(computed)6.80%5.65%7.09%6.25%8.90%
Per Share & EBITDA
EPS (Basic)$0.95$0.60$0.75$0.60$0.70
Wtd Avg Shares0.50B0.51B0.50B0.40B0.37B
EBITDA$1.51B$0.99B$1.16B$0.75B$0.58B
EBITDA Margin %(computed)21.83%18.21%21.53%20.14%19.64%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Rentokil Initial plc data

About Rentokil Initial plc (RTO) Income Statement

Rentokil Initial plc (RTO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RTO reported revenue of $6.91B, gross profit of $0.95B (gross margin 13.68%), and net income of $0.47B — a net profit margin of 6.80%.

Frequently asked questions

RTO · 4 questions

Rentokil Initial plc (RTO) reported revenue of $6.91B for 2025, up 27.2% year-over-year.

RTO revenueRTO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08